Atea Pharmaceuticals Inc (AVIR)
3.89
-0.04
(-1.02%)
USD |
NASDAQ |
May 10, 16:00
3.89
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals 1 Year Total Returns (Daily): 18.73% for May 9, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 09, 2024 | 18.73% |
| May 08, 2024 | 15.59% |
| May 07, 2024 | 17.61% |
| May 06, 2024 | 19.40% |
| May 03, 2024 | 22.22% |
| May 02, 2024 | 17.85% |
| May 01, 2024 | 18.10% |
| April 30, 2024 | 13.15% |
| April 29, 2024 | 13.46% |
| April 26, 2024 | 12.08% |
| April 25, 2024 | 12.16% |
| April 24, 2024 | 15.26% |
| April 23, 2024 | 13.72% |
| April 22, 2024 | 11.89% |
| April 19, 2024 | 12.05% |
| April 18, 2024 | 13.85% |
| April 17, 2024 | 10.09% |
| April 16, 2024 | 14.02% |
| April 15, 2024 | 14.63% |
| April 12, 2024 | 14.63% |
| April 11, 2024 | 11.59% |
| April 10, 2024 | 8.02% |
| April 09, 2024 | 11.73% |
| April 08, 2024 | 10.26% |
| April 05, 2024 | 15.11% |
| Date | Value |
|---|---|
| April 04, 2024 | 14.58% |
| April 03, 2024 | 13.70% |
| April 02, 2024 | 15.52% |
| April 01, 2024 | 19.40% |
| March 28, 2024 | 29.49% |
| March 27, 2024 | 26.58% |
| March 26, 2024 | 25.67% |
| March 25, 2024 | 27.33% |
| March 22, 2024 | 23.03% |
| March 21, 2024 | 19.88% |
| March 20, 2024 | 12.86% |
| March 19, 2024 | 4.51% |
| March 18, 2024 | 6.10% |
| March 15, 2024 | 9.86% |
| March 14, 2024 | 6.06% |
| March 13, 2024 | 18.40% |
| March 12, 2024 | 19.76% |
| March 11, 2024 | 20.66% |
| March 08, 2024 | 16.96% |
| March 07, 2024 | 21.79% |
| March 06, 2024 | 20.66% |
| March 05, 2024 | 13.03% |
| March 04, 2024 | 14.45% |
| March 01, 2024 | 36.92% |
| February 29, 2024 | 21.75% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.96%
Minimum
Feb 17 2022
36.92%
Maximum
Mar 01 2024
-50.82%
Average
-52.23%
Median
1 Year Total Returns (Daily) Benchmarks
| CEL-SCI Corp | -41.92% |
| AIM ImmunoTech Inc | -10.90% |
| IGC Pharma Inc | 48.57% |
| NovaBay Pharmaceuticals Inc | -90.89% |
| Protalix BioTherapeutics Inc | -57.19% |